stock Upgrades & Downgrades

Analysts' Actions: ARO, DUK, PPG.....

NEW YORK (TheStreet) -- CHANGE IN RATINGS

Arch Coal(ACI) was upgraded at Goldman Sachs from Sell. Valuation call, based on an $8 price target, Goldman said.

Assured Guaranty(AGO) was upgraded at UBS to Buy from Neutral. $18 price target. Favorable risk/reward, UBS said.

Alere(ALR) was downgraded at Capstone Investments from Buy to Hold. Company lacks near-term visibility, Capstone said.

Aeropostale(ARO) was upgraded at Wells Fargo to Market Perform. Business trends appear to be improving, Wells Fargo said.

Baker Hughes(BHI) was downgraded at Societe Generale from Buy to Hold. $47 price target. Company is seeing lower margins in North America, Societe Generale said.

CACI was upgraded from Underweight to Neutral at JP Morgan. $52 price target. Stock has declined 29% since earnings, JP Morgan said.

Carefusion(CFN) was upgraded at CLSA from Outperform to Buy. Expect strong 2013 guidance from management, CLSA said. $30 price target.

Cinemark(CNK) was initiated with a Buy rating at Wunderlich. Valuation call, based on a $30 price target.

Duke Energy(DUK) was upgraded at UBS to Buy from Neutral. $24 price target. Consolidated company creates scale and value creation potential, UBS said.

Eaton Vance(EV) was upgraded at Citigroup to Neutral from Sell. $23.50 price target. Shares approaching appropriate valuation, Citi said.

Express(EXPR) was initiated with a Neutral rating at JP Morgan. $20 price target. Company lacks near-term catalysts, JP Morgan said.

Forum Energy(FET) was initiated with a Buy rating at Deutsche Bank. $30 price target. Company is leveraged to strong secular growth markets, Deutsche said.

Green Dot(GDOT) was downgraded at Morgan Stanley from Overweight to Equal-weight. $25 price target. Company is facing regulatory and competitive pressures, Morgan Stanley said.

Heico(HEI) was upgraded at Bank of America/Merrill Lynch to Buy. Valuation call, based on a $54 price target, BofA/Merrill said.

Human Genome(HGSI) was downgraded at BMO Capital to Market Perform. $13 price target. GSK may drop its bid for the company, BMO Capital said.

Knight Transportation(KNX) was upgraded at Sterne Agee. $17 price target. Estimates were also increased, as the company should perform better over the coming quarters, Sterne Agee said

TheStreet Staff

05/24/12 - 08:58 AM EDT